Cannabichromene is a cannabinoid CB2 receptor agonist.

Michael UdohMarina SantiagoSteven DevenishIain S McGregorMark Connor

Published in: British journal of pharmacology (2019)

CBC is a selective CB2 receptor agonist displaying higher efficacy than tetrahydrocannabinol in hyperpolarizing AtT20 cells. CBC can also recruit CB2 receptor regulatory mechanisms. CBC may contribute to the potential therapeutic effectiveness of some cannabis preparations, potentially through CB2 receptor-mediated modulation of inflammation.

Keyphrases

induced apoptosis
randomized controlled trial
systematic review
cell cycle arrest
transcription factor
cell proliferation
endoplasmic reticulum stress
pi k akt